Human Microbiome - Global Market Outlook (2016-2022) - Analysis by Application, Disease, Product & Geography - Research and Markets

The "Human Microbiome - Global Market Outlook (2016-2022)" report has been added to Research and Markets' offering.

The Global Human Microbiome Market is expected to grow from $235.8 million in 2018 to $521.23 million by 2022 growing at a CAGR of 21.9% during the forecast period.

Increasing incidence of lifestyle diseases, growing geriatric population, and technological developments are some of the factors fueling the market growth. By product, Probiotics segment dominated the global market with largest share during the forecast period. North America and Europe commanded the market owing to the improved biotechnological and microbiological research infrastructure. However, Asia-Pacific is anticipated to grow at the highest CAGR owing to recuperating research infrastructure in the region.

Why Buy This Report:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and Recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Scope of the Report:

Applications Covered:

• Diagnostics
• Therapeutics
  

Diseases Covered:

• Cancer
• Acute Diarrhea
• Diabetes
• Mental Disorders
• Autoimmune Disorders
• Obesity
• Other Diseases
  

Products Covered:

• Foods
• Drugs
• Probiotics
• Diagnostic Devices
• Prebiotics
• Medical Foods
• Oral Rehydration Products
• Other Probiotics Supplements
  

Companies Mentioned

• ActoGeniX
• AvidBiotics
• E. I. du Pont de Nemours and Company
• ENTEROME Bioscience
• Merck & Co., Inc.
• Metabiomics Corp.
• MicroBiome Therapeutics, LLC
• Optibiotix Health Plc
• Osel, Inc.
• Rebiotix Inc.,
• Ritter Pharmaceuticals, Inc.
• Second Genome, Inc.
• Seres Therapeutics
• Vedanta Biosciences, Inc.
• ViThera Pharmaceuticals
• Yakult Honsha Co., Ltd.

Key Topics Covered:

1. Executive Summary

2. Preface

3. Market Trend Analysis

4. Porters Five Force Analysis

5. Global Human Microbiome Market, By Application

6. Global Human Microbiome Market, By Disease

7. Global Human Microbiome Market, By Product

8. Global Human Microbiome Market, By Geography

9. Key Developments

10. Company Profiling

For more information about this report visit https://www.researchandmarkets.com/research/3vphhv/human_microbiome

View source version on businesswire.com: http://www.businesswire.com/news/home/20170727005904/en/